Shoppers have long worried about hidden fees. Now New Jersey is taking aim at something more subtle: the possibility that two people could pay different prices for the same groceries based on their data.

The state’s new law is a direct shot at a pricing strategy that many consumers never see, even when it is happening right at the shelf or checkout.

What New Jersey banned, and why it matters

In July 2026, Governor Mikie Sherrill signed the Fair Price Protection Act, a law designed to stop retailers from using personal information to set individualized prices on groceries and other necessities. According to the governor’s office, the law bars businesses from using data such as purchase history, online activity, and location to charge different prices for identical products based on what an algorithm predicts a shopper will pay. That is the core of what critics call surveillance pricing.

The issue matters because this tactic can be almost invisible to the customer. A shopper may simply see a price on a screen, scan an item, or load an app discount without realizing the number could have been shaped by personal data rather than a broadly available sale. Consumer advocates have warned for years that digital retail tools make this kind of price discrimination easier to deploy at scale.

New Jersey lawmakers framed the practice as a fairness issue, not a ban on ordinary promotions. Legislative materials make clear that loyalty, membership, and reward programs can still exist, as long as personally identifiable information collected for those programs is not used to personalize the actual sale price of groceries. In other words, stores can still offer discounts, but they cannot secretly use your data profile to decide whether you should pay more.

The technology behind the checkout concern

The law arrives as major retailers have expanded digital tools across stores, from app-based coupons to electronic shelf labels that can update prices rapidly. Supporters of the measure argue that these systems create the infrastructure for frequent, individualized pricing changes that would have been far harder with paper tags and static signs. The concern is not just speed, but precision: software can test what different shoppers will tolerate.

Legislative documents in New Jersey specifically referenced surveillance-based price discrimination, dynamic pricing, and personalized pricing in grocery sales. That language is important because it captures more than a simple sale that changes by time of day. It targets price changes informed by surveillance data collected from consumers, a distinction that separates ordinary markdowns from data-driven pricing tailored to the individual.

The law also drew attention to electronic shelf labels. The governor’s office said the measure includes a one-year moratorium on the use of new electronic shelf labels while the New Jersey Innovation Authority studies the technology’s effects and impacts. That does not mean every digital price tag is illegal forever, but it signals deep concern that modern shelf technology could make opaque pricing easier to normalize before consumers fully understand it.

What shoppers and retailers should expect next

For consumers, the practical takeaway is simple: New Jersey is trying to preserve the idea that the posted grocery price should be the same for everyone unless a clearly defined discount applies. That could make checkout more predictable at a time when food budgets remain strained. It also gives regulators a clearer basis to challenge pricing practices that may have seemed novel or difficult to police only a few years ago.

For retailers, the new rules raise the compliance bar. Committee statements tied the measure to the state’s Consumer Fraud Act, meaning violations could carry serious legal and financial consequences. Businesses will need to separate legitimate promotions from any pricing model that relies, even in part, on personal data to alter what a shopper pays for groceries or similar food items.

More broadly, New Jersey’s move could become a template for other states. Across the country, policymakers have been cracking down on junk fees, opaque surcharges, and misleading advertised prices. This law pushes that effort into a newer frontier: not just the fees added at checkout, but the hidden logic that may determine the price before the shopper ever reaches the register.

Weather disruptions, export risk overseas, and meatpacking cutbacks are all landing on U.S. agriculture at the same time. In western Illinois and the broader Corn Belt, that convergence now includes Tyson Foods’ decision to end operations at its Joslin-area beef facility on August 13, 2026, as grain traders also react to storm damage concerns and renewed Black Sea supply anxiety. Pro Farmer said those forces were all moving the market in the same mid-August stretch, with corn, wheat, cattle, and hog contracts all under pressure or support for different reasons.

Tyson confirms a sudden beef network restructuring

Tyson Foods said on August 13 that it will end operations at its Joslin, Illinois, beef facility as part of a broader restructuring of its beef network. In the same announcement, the company said it will also end operations at its Eagle Mountain, Utah, case-ready facility and pursue the sale of its Pasco, Washington, beef plant, while concentrating harvest capacity in Dakota City, Nebraska, Holcomb, Kansas, and Amarillo, Texas. Tyson said the moves are intended to create “a more competitive footprint” during what it described as one of the most historic cattle shortages the U.S. has experienced.

The company did not publicly release a worker count in that August 13 statement. What is confirmed is the location of the plant tied to the closure: federal EPA facility records list Tyson Fresh Meats’ Joslin operation at Highway 92 and I-88, 28424 38th Ave. N, Hillsdale, Illinois, in Rock Island County. Illinois’ WARN guidance says employers must notify the state when they plan a plant closure or mass layoff, but as of the latest state pages reviewed, a public notice with Joslin-specific worker totals was not readily posted.

The timing mattered immediately for markets. Pro Farmer reported on August 14 that cattle futures were under pressure heading into the weekend after Tyson announced the Joslin closure. That made the plant decision more than a local employment story; it became part of the same trading session that was already digesting fresh USDA supply data and volatile weather.

Western Illinois feels the local shock first

For the Quad-Cities side of Illinois, the confirmed impact starts with the loss of a major beef-processing site near Joslin and Hillsdale. Tyson has not released a comprehensive public list of affected western Illinois communities, local supplier relationships, or employee counts by town. It has said only that it recognizes the impact on team members and communities and will help affected workers apply for open jobs at other facilities.

That leaves several local questions unresolved. The company has not publicly detailed the final operating day for each department inside the Joslin facility beyond the August 13 closure announcement, and it has not published a full breakdown of severance terms, transfer opportunities by state, or how much of the plant’s capacity will be reassigned to each remaining beef site. No city-by-city Illinois closure list was included in Tyson’s release because the company is closing the single Joslin-area facility rather than a retail chain footprint.

The plant sits in a region where agriculture, freight, and food manufacturing overlap closely. That matters because the same Pro Farmer market summary that flagged Tyson’s decision also described heavy, widespread storms with high winds and excessive precipitation across a broad swath of the Corn Belt. In practical terms, western Illinois is now confronting a plant closure while nearby farm country is also managing weather-related field and transport uncertainty.

Why these three forces are colliding now

The most direct reason Tyson gave for the closure is the U.S. cattle cycle. In its August 13 release, the company cited recent USDA cattle inventory data and continued evidence of limited heifer retention, saying supply constraints are likely to persist. Tyson had already told investors on August 3 that USDA projects domestic beef production to decline about 3% in fiscal 2026 and that Tyson expects an adjusted operating loss of $650 million to $500 million in its beef segment, underscoring the financial pressure behind the network reset.

At the same time, grain markets have been absorbing fresh geopolitical risk from the Black Sea. Reuters reported on July 30 that a Ukrainian drone attack caused significant damage to a major Russian grain export terminal at Taman with capacity of 5 million metric tons, while shipping in the Sea of Azov and Kerch Strait had been halted since July 10 because of drone attacks. Earlier, on July 15, Reuters reported that Ukraine had lost about a third of its Black Sea grain export capacity due to intensifying Russian missile and drone attacks, with monthly grain shipments slipping from about 6 million metric tons to roughly 4 million.

That overseas disruption helps explain why wheat futures found support even as U.S. livestock contracts weakened. Pro Farmer said wheat rallied on intensifying fighting in the Black Sea that damaged Russian and Ukrainian grain facilities and raised export concerns, while storms across the Corn Belt added another layer of uncertainty for row-crop movement and condition. For customers and residents in Illinois, the immediate takeaway is confirmed but narrow: Tyson’s Joslin plant is being shut, the company says support for workers will follow, and broader grain and livestock markets remain driven by weather, cattle scarcity, and disrupted export channels abroad.

National guidance on metabolic health has increasingly tied liver health and blood sugar control to the same day-to-day food choices. That overlap is especially relevant as clinicians track rising rates of type 2 diabetes and metabolic dysfunction-associated steatotic liver disease, or MASLD, the condition formerly known as NAFLD. In current recommendations from federal agencies and major medical groups, three ordinary foods show up repeatedly: oats, beans, and unsweetened yogurt.

Oats show up in guidance built around lower-glycemic, higher-fiber eating

The National Institute of Diabetes and Digestive and Kidney Diseases states that people trying to prevent or manage fatty liver disease may benefit from eating more low-glycemic foods, including whole grains, because those foods affect blood glucose less than high-glycemic choices such as white bread or white rice. The American Diabetes Association’s 2025 Standards of Care also advises people with diabetes or at risk for it to emphasize carbohydrates from whole grains and to consume at least 14 grams of fiber per 1,000 calories.

Oats fit both of those standards in a practical way because they are a whole grain and a source of soluble fiber. The National Heart, Lung, and Blood Institute lists oatmeal among foods that provide soluble fiber, a type of fiber long used in heart-healthy dietary patterns that also supports slower digestion than refined grains. That does not make oats a treatment, and federal guidance does not single out oatmeal as a liver therapy on its own.

What is confirmed is that oats align with the broader pattern recommended for both glycemic management and liver-friendly eating: minimally processed, higher-fiber, lower-sugar meals. What is not known from current guidance is a single national threshold for how much oatmeal alone changes liver fat in the general population. The practical meaning for shoppers is narrower but clear: plain oats are one of the most accessible ways to swap a refined breakfast for a whole-grain option that fits current diabetes and liver recommendations.

Beans and other legumes are consistently tied to steadier carbohydrate quality

The American Diabetes Association’s 2025 nutrition guidance encourages carbohydrates from legumes, alongside vegetables, fruit, dairy, and whole grains, rather than foods high in added sugar and refined starch. That recommendation matters because legumes deliver carbohydrate with fiber and plant protein, a combination that generally produces a slower glucose response than many processed snack foods or white-flour side dishes.

Federal and specialty liver guidance points in the same direction. NIDDK recommends low-glycemic foods as part of an eating pattern that can help prevent or manage fatty liver disease, and European MASLD guidelines recommend improving diet quality while limiting ultra-processed foods and sugar-sweetened beverages. Beans fit that framework without requiring specialty products or a branded meal plan.

The confirmed takeaway is that beans are not being promoted as a cure, but they are repeatedly included in the kinds of eating patterns used for cardiometabolic disease. What has not been publicly established in those broad guidelines is that one specific bean variety is superior for everyone. For consumers, the significance is practical: black beans, chickpeas, lentils, and similar legumes can replace more refined starches in meals while matching the fiber-forward, minimally processed approach that major guidance documents continue to emphasize.

Unsweetened yogurt remains one of the dairy foods included in diabetes-focused plans

The American Diabetes Association’s 2025 Standards of Care says people with diabetes and those at risk are encouraged to focus on carbohydrates from foods such as dairy, including milk and yogurt, while minimizing foods with added sugar that displace more nutrient-dense options. The National Institutes of Health’s nutrition materials also list yogurt as a source of key nutrients, including protein and potassium, depending on the product.

For liver health, the significance is less about yogurt as a standalone intervention and more about what it can replace. Liver guidance from NIDDK and the American Association for the Study of Liver Diseases emphasizes limiting added sugars, refined carbohydrates, and saturated fat while favoring higher-quality eating patterns. An unsweetened or lower-added-sugar yogurt can fit that approach better than many sweetened desserts or sugary breakfast items.

What is confirmed is that yogurt appears in mainstream diabetes nutrition guidance as a nutrient-dense food category, not as a prescription product. What remains product-specific is the sugar content, fat level, and portion size, which vary widely across brands and flavors. For shoppers, that means the label matters: plain or lower-sugar yogurt is the version most consistent with the broader advice now used in blood sugar and liver care.

The U.S. meat industry has spent months grappling with tight cattle supplies, high input costs and repeated restructuring moves by major processors. In western Illinois, that broader pressure turned into an immediate workplace shock on August 13, when Tyson Foods workers at the Joslin-area beef plant were informed their regular shift would be their last active day. The closure centers on the company’s beef operation serving the Quad-Cities region from its facility in Hillsdale near Joslin.

Tyson confirms an abrupt end to operations at its Joslin-area beef plant

Tyson Foods confirmed on August 13 that it will end operations at its Joslin, Illinois, beef facility and also close its Eagle Mountain, Utah, case-ready facility, while pursuing the sale of its Pasco, Washington, beef plant, according to company statements cited in widespread coverage of the announcement. The Illinois facility is commonly identified in Tyson job postings as the Joslin plant, with the work site listed in Hillsdale. State materials and local reporting indicate the closure affects more than 2,500 jobs at the Illinois operation.

Workers and community members described the news as abrupt because employees had reported for what they expected to be a normal shift before learning production was ending that day, according to local and social reporting that circulated after the announcement. Tyson has not publicly released a detailed minute-by-minute account of how employees were notified inside the facility. It has, however, confirmed the facility is being closed as part of a larger change in its beef network.

Illinois law generally requires 60 days’ notice for covered plant closings, and the state explains that employers subject to the WARN Act must provide notice when a plant closing or mass layoff is planned. As of Monday, August 17, the publicly posted Illinois archived WARN page did not yet provide an easily accessible downloadable July-or-later report confirming the Tyson notice details in a web-readable format. The company’s precise filing date, whether the notice was submitted as final or conditional, and the exact first layoff date listed in the filing were not publicly clear from the state pages available online Monday.

What is confirmed in Illinois, and what remains unclear for the Quad-Cities region

The closure’s local impact is centered on the Quad-Cities labor market, where the plant has long been a major industrial employer near Joslin and Hillsdale in Rock Island County. Tyson job postings reviewed online still identified the site as a production location in Hillsdale as recently as last month, underscoring how recently the operation was actively recruiting. That geographic detail matters because the plant’s effect reaches beyond one village and into the broader western Illinois workforce.

What is confirmed is that the Illinois facility is closing and that the decision directly affects thousands of workers tied to the plant. What is not yet fully public is a complete official list of affected job titles, the breakdown of how many employees live in each surrounding city, or the exact schedule for final separation from payroll. The company also has not released a public city-by-city list showing how many affected workers come from Joslin, Hillsdale, East Moline, Moline, Rock Island or other nearby communities.

There is also no publicly posted Illinois state summary, as of Monday, that spells out a facility street address and exact worker count in a searchable notice page. That means readers should be careful about any circulating figures beyond the broad counts reported by credible outlets and repeated in public discussion. For residents, the practical near-term reality is simpler: active production at the plant is ending, while more detailed state paperwork and any workforce-transition disclosures may emerge later.

Tyson’s stated reason is the cattle shortage, with broader beef-market pressure behind it

Tyson’s explanation for the closure is rooted in the economics of the beef business. Recent Tyson investor materials warned repeatedly about fluctuations in the cost and availability of live cattle, and Bloomberg reporting this summer described the U.S. cattle herd as sitting at a decades-low level while beef processors were paying sharply higher prices for scarce animals. That backdrop has squeezed processors even as consumers continue seeing high beef prices in stores.

The company’s recent financial disclosures also show that cattle supply constraints and livestock availability remain central risks to its beef segment. Industry coverage in late July noted that renewed Mexican cattle imports could ease some pressure, but that the shortage had already added significant strain for packers including Tyson. In that context, reducing slaughter or processing capacity becomes a company response to limited supply rather than a signal of weakening consumer demand alone.

For Illinois residents and customers, Tyson has not announced a consumer-facing disruption such as a recall or retail product withdrawal tied to the Joslin closure. What customers should expect instead is a business transition with workforce consequences in western Illinois and a continued industry focus on beef supply. Tyson has said it is reshaping its network while it evaluates other beef assets, and the broader market continues to contend with constrained cattle numbers and elevated costs.

A new federal push on food ingredients is drawing national attention as the Trump administration expands its food-chemical and nutrition agenda. The headline change is a proposed overhaul of how companies use the “generally recognized as safe,” or GRAS, pathway, alongside a separate federal effort to define ultra-processed foods. For shoppers in the U.S., the practical effect is narrower than the rhetoric: the government is proposing more reporting and more oversight, not an immediate rewrite of ingredient lists.

The proposal would require more GRAS notices, not instant ingredient bans

The clearest federal action came March 10, 2025, when HHS said Secretary Robert F. Kennedy Jr. directed the FDA to explore rulemaking to eliminate the self-affirmed GRAS pathway, under which companies can currently determine on their own that some ingredients are generally recognized as safe without notifying the agency, according to HHS. FDA’s Human Foods Program later listed GRAS reform as a 2026 priority and said it plans a proposed regulation requiring submission of GRAS notices for all new substances claimed to be GRAS, according to the agency.

That is a significant regulatory shift, but it is still a proposal rather than a final rule. Under the FDA’s current framework, companies may voluntarily submit GRAS notices, and FDA maintains a public inventory of those filings and response letters. The proposed change would move that process toward mandatory notification for new substances, giving regulators greater visibility into what is entering the food supply.

What it does not do, at least at this stage, is automatically ban ingredients already in products on store shelves. It also does not mean FDA would newly “approve” every ingredient before consumers buy food made with it. The central change is procedural: companies would have to tell FDA about their GRAS determinations, creating a larger public and regulatory record than exists under the current voluntary system.

For consumers nationwide, the immediate impact is limited and mostly about transparency

Because this is a federal proposal, it is national in scope rather than tied to one state or city. What is confirmed is that FDA has signaled a broader food-chemical review agenda for 2026, including continued reassessments of substances such as phthalates, propylparaben, BHA and BHT, according to the agency’s Human Foods Program priorities and its list of chemicals under review. What is not yet known is the final wording of any GRAS rule, its effective date, or whether manufacturers would get transition time after publication.

That uncertainty matters for grocery shoppers. The administration’s announcement does not create a new nationwide label requirement for foods already on the market, and it does not require companies to reformulate products immediately. FDA’s own rulemaking process also requires a public comment period before a proposal can be finalized, and the agency says proposed regulations are published in the Federal Register and revised with public input.

In practical terms, shoppers should expect a slower regulatory timeline than some headlines suggest. Any visible changes on packaging, ingredient disclosures or company compliance systems would depend on a final rule that has not yet been issued. For now, the most concrete change is that Washington is signaling tighter oversight of information companies provide to regulators about food ingredients.

The broader context includes ultra-processed foods and a wider food-chemical review

The GRAS proposal is unfolding alongside a separate federal initiative on ultra-processed foods. On July 23, 2025, HHS, FDA and USDA announced a joint request for information to help create what they described as a federally recognized uniform definition of ultra-processed foods, and FDA later said the comment period was extended to Oct. 23, 2025. That effort is about creating a research and policy framework, not a new ban or mandatory warning label.

FDA has also tied the issue to a wider food-safety and nutrition strategy. In its 2026 priority agenda, the Human Foods Program said the agency would expand post-market safety reviews of marketed food chemicals and continue work on ultra-processed foods after gathering data and comments from the 2025 request for information. The agency has separately published a list of select chemicals under review, underscoring that GRAS reform is one part of a broader oversight push.

For consumers, the practical takeaway is that food policy may become more transparent before it becomes visibly different at the shelf. The most immediate change would be more mandatory disclosure from manufacturers to regulators if the GRAS rule is finalized. Until then, the federal government is still in the stage of collecting comments, drafting definitions and building the record for future action.

Tattoos remain common in the United States, but the science around what happens to ink after it enters the body is still developing. New research has narrowed that question to what happens beyond the skin, with scientists documenting tattoo ink in lymph nodes and studying how the body responds over time. The latest findings do not show that every tattoo causes illness, but they do show the ink may do more than remain where it was placed.

New research documents tattoo ink beyond the skin

A study published in Proceedings of the National Academy of Sciences on December 2, 2025, reported that tattoo ink can accumulate in draining lymph nodes and trigger persistent immune activity, according to the paper’s abstract and summary. The researchers said they examined commonly used commercial tattoo inks and found that ink components moved through lymphatic pathways after tattooing. The study also reported altered responses to vaccination in an experimental model, tying the finding not just to pigment movement but to measurable immune effects.

That broad conclusion builds on earlier evidence cited by the German Federal Institute for Risk Assessment, which said deposition of tattoo pigments in lymph nodes has been known for years and had already been documented in prior studies. In a February 4, 2025 research release, the institute said a new clinical study traced the path and metabolism of liquid components of tattooing agents in the body for the first time. That work involved 24 volunteers who each received a tattoo of their choice as part of the study, according to the release summary.

The newer PNAS study focused on immune consequences rather than only ink migration. Its authors reported chronic inflammation in draining lymph nodes in their model and said the findings support further safety research into long-term tattoo ink exposure. That does not amount to a blanket finding that tattoos are unsafe, but it does mark a more specific, measurable effect than the older observation that pigment can spread beyond the skin.

What is confirmed, and what remains unclear for the public

What is confirmed is relatively narrow: pigments and other tattoo-related materials can leave the skin site and reach nearby lymph nodes, and researchers are now documenting inflammatory and immune-system effects in greater detail. Separate pathology reporting published in 2026 also described tattoo ink deposition in lymph nodes on histologic review, reinforcing that clinicians can encounter tattoo pigment in tissue samples. That matters because pigment-bearing lymph nodes can complicate interpretation in some medical settings, particularly imaging or pathology workups.

What is not yet known is equally important. The available studies do not establish that a person with a tattoo will develop cancer, autoimmune disease, or vaccine problems. The newer immune-response findings were reported from an experimental model, and researchers themselves said more work is needed to understand what the results mean for long-term human health.

There is also no single public database that tells consumers which tattoo inks, colors, or brands carry the highest long-term risk across all outcomes. Earlier research and risk reviews have noted that particles can vary by pigment type and that metals from tattoo needles can also be deposited in skin and lymph nodes under some conditions. But the science is still evolving, and public health agencies have not issued a universal determination that ordinary tattooing produces a defined long-term disease outcome in the general population.

Why this issue is drawing more attention now

One reason this topic is getting renewed attention is scale. Tattoos are common, so even uncertain long-term effects draw interest from researchers, pathologists, and regulators when evidence begins to accumulate. The 2025 PNAS paper framed its work around the long-term presence of tattoo ink in the body and the need to better understand how that persistent exposure interacts with immune function.

Another reason is that researchers are moving from documenting where ink goes to studying what it does once it gets there. A Danish twin study published in January 2025 reported an association between tattoo ink exposure and lymphoma and skin cancers, while also noting that tattoo ink is known to transfer from skin to blood and accumulate in regional lymph nodes. An association does not prove causation, but the study added to concern about whether chronic exposure and inflammation may matter over time.

For people who already have tattoos, the practical takeaway is limited but concrete: the ink may not stay only in the skin, and that is now supported by multiple lines of research. Scientists have not issued a universal warning against tattooing based on these findings alone, but the current evidence points to a need for continued study of ink composition, lymph node deposition, and immune effects. That keeps the issue in the category of active medical research rather than settled consumer guidance.

Ground cinnamon is one of the most common baking and spice cabinet staples in the U.S., and federal regulators have continued to examine it more closely after a wider food safety investigation tied contaminated cinnamon to lead exposure concerns. That scrutiny narrowed sharply on March 6, 2024, when the FDA issued a public health alert and recommended voluntary recalls for certain ground cinnamon products after testing found elevated lead levels. The agency’s actions, later expanded with additional product notices, turned an everyday pantry item into a continuing food safety story with national reach.

FDA alert put specific cinnamon brands and lot codes under recall pressure

The FDA said on March 6, 2024, that testing showed certain ground cinnamon products contained elevated levels of lead and that prolonged exposure could be unsafe, especially for children. In the same action, the agency recommended voluntary recalls for products from six distributors after a targeted survey of discount-store cinnamon, according to the FDA’s safety alert. The alert followed the October 2023 recall of apple cinnamon puree and applesauce pouches that federal investigators linked to contaminated cinnamon used as an ingredient.

One of the clearest company recalls that followed was issued by Colonna Brothers, Inc. of North Bergen, New Jersey, on March 6, 2024. The company recalled 1.5-ounce Marcum Ground Cinnamon and 2.25-ounce Supreme Tradition Ground Cinnamon because of elevated lead levels, according to its FDA-posted announcement. The affected Marcum lot codes were Best By 10/16/25 10DB and Best By 04/06/25 0400B1.

The affected Supreme Tradition lot codes were Best By 09/29/25 09E8, 04/17/25 04E11, 12/19/25 12C2, 04/12/25 04ECB12, 08/24/25 08A, 04/21/25 04E5, and 09/22/2025 09E20, the company stated. The FDA alert described lead concentrations in the March 2024 group ranging from 2.03 to 3.4 parts per million. The FDA advised consumers not to buy and to throw away the products named in the alert, while Colonna Brothers said customers with the recalled jars could discard them or return them to the store for a full refund.

State-by-state distribution details show how widely the affected products moved

The federal notices make clear that this was not limited to one retailer or one region. Colonna Brothers said its recalled cinnamon was distributed nationwide through retail stores and mail order, but its company announcement did not publish a full 50-state list. In the FDA’s original March 6, 2024 alert materials, specific sampled states tied to some of the affected products included Missouri and Maryland, while the named retail chains included Save A Lot, Dollar Tree, Family Dollar, La Joya Morelense, La Superior SuperMercados, Patel Brothers, and SF Supermarket.

Later FDA updates added more brands and more specific state distribution information. In the agency’s expanded cinnamon alert, Durra brand ground cinnamon was listed as distributed to grocery stores in California and Michigan; Wise Wife brand ground cinnamon was listed as distributed to retailers in New Jersey, New York, Florida, Maryland, Minnesota, Oklahoma, and Ohio; Super Brand Cinnamon Powder 4 oz was tied to an Asian supermarket in Little Rock, Arkansas; Asli Cinnamon Powder 7 oz was tied to Columbia, Missouri; SWAD Ground Cinnamon was tied to Connecticut; Compania Indillor Orientale Ground Cinnamon was tied to Connecticut; ALB Flavor Ground Cinnamon was tied to Connecticut; and Shahzada Brand Cinnamon Powder 7 oz was tied to New York.

That means the states specifically named in the FDA materials include Arkansas, California, Connecticut, Florida, Maryland, Michigan, Minnesota, Missouri, New Jersey, New York, Ohio, Oklahoma, and Virginia. The company has not released a comprehensive city-by-city list for every recalled or alerted product, and some FDA entries said retail location details were still being requested. No single FDA enforcement report number, such as a Recall #F-series classification, was clearly published in the underlying company recall notice reviewed here.

The broader concern came from lead testing, not a change in how cinnamon is usually used

The immediate cause of the March 2024 FDA action was targeted product testing. The agency said it began a survey of ground cinnamon sold at discount retail stores after the October 2023 applesauce pouch recall raised concerns about lead toxicity in children and pointed investigators toward cinnamon as the ingredient of concern. FDA officials later said state partners in Maryland and Missouri also collected samples through the Laboratory Flexible Funding Model.

The FDA has been careful to distinguish between the highly contaminated cinnamon associated with the applesauce pouch case and the lower, but still concerning, lead levels found in the later ground cinnamon survey. In the March 2024 alert, the agency said the ground cinnamon products it flagged contained lead levels significantly below the thousands of parts per million found in cinnamon tied to the puree pouch case. Even so, the FDA said prolonged exposure to the products in the cinnamon alert could be unsafe and recommended market removal.

For shoppers, the practical takeaway remains limited to the specific products and codes identified in federal notices and company recall announcements. The FDA said consumers should throw away and not buy the products listed in its alert, while Colonna Brothers said buyers of its recalled Marcum and Supreme Tradition products could discard them or return them for a full refund. As of the FDA materials reviewed, no illnesses had been reported in connection with the recalled Colonna Brothers products, and the agency said it would continue working with manufacturers, distributors, and retailers to remove unsafe cinnamon from the market.

Federal regulators are taking a new step in how processed food ingredients enter the U.S. market, part of a broader push to tighten oversight of the food supply. On August 10, 2026, the Food and Drug Administration announced a proposed rule that would require manufacturers to notify the agency before introducing new food ingredients or additives under the “generally recognized as safe,” or GRAS, pathway. The change would affect food makers nationwide, but critics said the proposal still leaves companies with substantial authority to decide for themselves what can go into food.

FDA proposes a new notice requirement for food additives

The FDA said the proposal would replace a long-standing system that lets companies self-affirm that a substance is GRAS without telling the agency. Acting FDA Commissioner Kyle Diamantas said the change would give regulators “comprehensive visibility” into ingredients entering the market, according to remarks reported by the Associated Press on August 10. The agency said it will accept public comments for 120 days before taking further action.

The scale of the issue is significant. The Associated Press reported that roughly 10,000 additives are allowed in U.S. food, including preservatives, thickeners and packaging-related substances. Under the current framework, manufacturers can decide independently whether some new substances qualify as GRAS, and the FDA has acknowledged that notification is encouraged but not required.

Under the new proposal, companies would have to submit their safety rationale before marketing a new ingredient under the GRAS pathway. Diamantas said the FDA would aim to review those submissions within 180 days and could ask for more information or request a delay if safety questions arise, according to the Associated Press. The FDA also said it plans to publish a list of company-submitted ingredients, though former FDA food official Susan Mayne told the AP that appearing on that list would not mean the ingredient had been determined safe by the agency.

The impact is national, but the full reach is not yet known

Because the FDA proposal applies at the federal level, its practical effect would extend across all 50 states, including grocery shelves, packaged foods and processed products sold in local supermarkets. What is confirmed is the rule would apply to future ingredients introduced through the GRAS pathway if finalized. What is not yet known is how many companies would change product development plans, delay launches or shift to other regulatory channels once the rule is in place.

The government has not released a state-by-state breakdown of foods or manufacturers that would be affected. It also has not published a comprehensive list of self-affirmed GRAS substances currently used without FDA notification. That means shoppers in states from California and Texas to New York and Florida would not immediately see a product list tied to this proposal.

The FDA has also not said when any final rule would take effect after the 120-day comment period. In practical terms, that means there is no immediate change at checkout, in restaurant supply chains or in packaged food labels. The proposal is a procedural shift in oversight, not a ban on specific additives now on store shelves.

Critics say transparency is improving, but independent review is still limited

The main reason the announcement has drawn mixed reactions is that it addresses notification, not automatic premarket approval. Susan Mayne, now a Yale public health expert, told the Associated Press that the proposal is “a reasonable first step” toward a fuller inventory of ingredients, but she said most self-affirmed GRAS ingredients still would not be reviewed by the FDA for safety. That distinction is central to criticism from consumer groups that have argued for years that the GRAS system functions as a loophole.

Melanie Benesh of the Environmental Working Group said the new framework should include stronger safety standards and independent FDA review before chemicals are used in food, according to the AP. Food industry representatives, by contrast, have maintained that internal safety reviews can be as rigorous as the government’s process. The current debate traces back to changes beginning in 1997, when the FDA started allowing companies to independently conclude that certain additives were safe based on publicly available science and expert consensus.

The additive proposal arrived alongside a separate FDA announcement that it had completed work on the federal government’s first definition of ultra-processed food and sent it to the White House for review. Health and Human Services Secretary Robert F. Kennedy Jr. said the two actions would change how the federal government oversees food ingredients and understands the foods Americans eat, according to remarks at HHS headquarters. For consumers, the immediate takeaway is that the proposal would increase federal visibility into future additives, while broader powers to require full FDA review would still depend on Congress.

Restaurant dealmaking has stayed active in quick service and fast casual as investors chase brands with room to grow across franchise markets. Bonchon, the Korean fried chicken chain known in the U.S. for its double-fried chicken and sauce-driven menu, is the latest brand to change hands. The transaction points to continued demand for restaurant concepts with international reach and a scalable operating model.

Bonchon’s ownership is being divided by region

Bonchon said it agreed to be acquired by two buyers, with Minor Food taking the chain’s business outside the Americas and Serruya Private Equity taking the Americas business, according to reporting by Nation’s Restaurant News. The publication reported that the deal was expected to close in August and described Bonchon as a system with about 500 units worldwide across nine countries, including roughly 150 in the United States. That makes this a sizeable ownership change for a brand that has built a meaningful U.S. footprint while keeping a much larger presence in Asia.

The structure of the sale is unusual because the buyers are splitting the system by geography rather than placing the entire chain under one owner. Minor Food is a subsidiary of Minor International and already has ties to the brand as Bonchon’s master franchisee in Thailand, according to Nation’s Restaurant News and Minor Food’s corporate materials. Serruya Private Equity, based in Toronto, is taking the Americas side with plans centered on growth across the United States, Canada, Mexico and Chile, per the same report.

Bonchon chief executive Suzie Tsai said in a company statement cited by Nation’s Restaurant News that the transaction is intended to accelerate the brand’s expansion. Michael Serruya, chair of Serruya Private Equity, said Bonchon has a differentiated product, a loyal customer base and a franchise model with room to scale, according to the report.

What the deal means in the U.S. market

For U.S. diners, the clearest confirmed change is at the ownership level, not at the store level. Nation’s Restaurant News reported that Serruya will control Bonchon’s outlets in the Americas, which includes the chain’s approximately 150 U.S. restaurants. Bonchon has not released a comprehensive public list tied to the transaction identifying which specific U.S. cities or states could see the earliest expansion activity under the new ownership structure.

What is known is that the U.S. remains central to Bonchon’s growth strategy. The chain made its U.S. debut in New York City in 2006, according to Nation’s Restaurant News, and has since expanded through a mix of full-service and fast-casual formats, as well as ghost kitchens and mall locations. That operating flexibility is one reason the brand has been able to enter different types of trade areas without relying on a single restaurant format.

What is not yet known is whether the ownership change will lead to immediate menu, pricing or store design changes in the United States. No public filing or company statement in the source material lays out a timetable for operational changes at specific U.S. locations. For now, the confirmed U.S. takeaway is that Bonchon’s Americas business is changing hands while the brand continues to present franchise growth as a priority.

Why buyers were interested in Bonchon

The rationale behind the deal appears to be growth, scale and category positioning. Nation’s Restaurant News described Bonchon as one of the more compelling global restaurant brands in the market, with buyers highlighting its strong customer following and franchise potential. The chain sits at the intersection of two attractive trends for investors: chicken remains one of the most expansion-friendly restaurant categories, and Korean flavors have become more mainstream in U.S. dining.

Tsai said in a statement cited by Nation’s Restaurant News that Bonchon’s momentum reflects broader consumer adoption of Korean flavors. That context matters because private equity and strategic buyers often pay closest attention to concepts that can travel well across markets while staying distinctive. Bonchon’s sauce profiles, format flexibility and international recognition all support that case, especially for operators looking for growth beyond the crowded burger and pizza categories.

The backgrounds of the two buyers also help explain the transaction. Minor Food is one of Asia’s larger restaurant operators, with thousands of restaurants across multiple countries, according to Nation’s Restaurant News and Minor Food materials. Serruya, meanwhile, has a long history investing in restaurant brands, and Michael Serruya said the firm and Minor share a long-running approach built around disciplined franchise growth and operations. For customers, that means Bonchon is moving into the hands of owners who are buying the brand for expansion, not for a public retreat from the market.

As mall owners and restaurant operators search for ways to keep diners spending longer on-site, food halls have increasingly become testing grounds for chef-led, nostalgia-focused concepts. In Los Angeles, that trend took a clear form on September 2, 2024, when B.J. Novak’s Chain began a six-month residency at Topanga Social inside Westfield Topanga, bringing upscale riffs on fast-food dishes many customers already knew.

Chain brings four chefs and a six-month residency to Westfield Topanga

Chain, the food concept created by actor B.J. Novak and partners including chef Tim Hollingsworth, opened its Topanga Social residency on September 2, 2024, according to Nation’s Restaurant News. The project translated Chain’s earlier pop-up model into a food-hall format, with four chefs each building a dish around a recognizable fast-food reference point. The verified scale of the launch was four chef-created menu items plus two related concepts, Chain Snacks and ByChain, planned as part of the residency.

Roy Choi contributed a Charred Chicken Teriyaki Bowl, a mall-food reference that connected directly to the setting. Calvin Eng developed a Crispy Cantonese Fishwich inspired by McDonald’s Filet-O-Fish, while Mason Hereford created a Spicy Chicken Chainwich based on the Wendy’s spicy chicken sandwich. Mei Lin added a Mapo Wagyu Cruncho Perfecto, a Sichuan-influenced take on the Crunchwrap format, according to the publication’s report and chefs’ statements provided to the outlet.

The concept’s stated goal was not exact duplication. Mei Lin said the idea was to capture the feeling of eating a familiar chain item and take it in a different direction, according to Nation’s Restaurant News. That positioning placed Chain between chef collaboration, branded nostalgia, and mall dining, rather than in direct competition with the original national chains that inspired the menu.

The Los Angeles impact centered on Topanga Social’s role as a regional food destination

For Los Angeles diners, the significance of the residency was tied as much to the venue as to the menu. Topanga Social is the chef-driven food hall at Westfield Topanga in the San Fernando Valley, and Westfield has described it as part of the mall’s broader dining and entertainment district. Business announcements tied to the project said the food hall spans more than 20 eateries, making it one of the larger mall-based culinary venues in the region.

The Chain residency gave Topanga Social a limited-run attraction built around well-known chefs with connections to Los Angeles and beyond. Choi’s participation added a hometown link, and his statement to Nation’s Restaurant News described mall food as part of his own upbringing. That local framing mattered because the residency was not announced as a standalone restaurant elsewhere in the city; it was specifically positioned inside a mall environment that depends on repeat regional traffic.

What remains less clear is how much customer volume the residency generated over its full run. Neither Westfield nor the available reports released public attendance figures, sales data, or a full performance breakdown for the six-month program. Publicly available reporting also did not provide a complete month-by-month list of all ByChain brand collaborations that were expected to rotate into the space later.

The broader context is the intersection of nostalgia, food halls, and retail reinvention

The Chain project arrived during a period when restaurant operators were using limited-time collaborations and familiar menu cues to lower the barrier to trial. Nation’s Restaurant News reported that Chain had evolved from invitation-only dinners into a broader event and food-festival concept before moving into a food-hall residency. That progression reflected a wider industry strategy: use recognizable flavors and formats to attract customers, while giving chefs room to add technique, regional influence, or premium ingredients.

The mall setting added another layer of context. Westfield and affiliated property materials have presented Topanga Social as a major component of the center’s repositioning toward dining, entertainment, and longer visits. In practical terms, that means food is no longer treated as support for retail alone; it is part of the reason customers make the trip. A concept like Chain fit that strategy because it offered a time-limited reason to visit beyond standard food-court options.

For customers, the result was a menu built on familiar references but sold as a special-event experience inside a large Los Angeles shopping center. The residency was announced as lasting six months beginning September 2, 2024, according to Nation’s Restaurant News, giving diners a defined window to try the concept while Topanga Social continued to market itself as a destination for chef-driven dining.